Risk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancers

World Journal of Gastroenterology

Volumn 19, Issue 32, 2013, Pages 5227-5237

  Peng, Jia Yuan ^a   Li, Zhong Nan ^a   Wang, Yu ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Local recurrence; Neoadjuvant chemoradiotherapy; Rectal cancer

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADJUVANT CHEMORADIOTHERAPY; ANASTOMOSIS LEAKAGE; CANCER CELL; CANCER RECURRENCE; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; PROGNOSIS; RECTUM CANCER; RECTUM PERFORATION; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT RESPONSE; TUMOR INVASION; ADJUVANT THERAPY; PATHOLOGY; PATIENT SELECTION; RECTAL NEOPLASMS; RISK ASSESSMENT; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

CHEMORADIOTHERAPY, ADJUVANT; HUMANS; LYMPHATIC METASTASIS; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; RECTAL NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84882978830     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i32.5227     Document Type: Review

References (101)

1. Garcia-Aguilar J, Smith DD, Avila K, Bergsland EK, Chu P, Krieg RM. Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial. Ann Surg 2011; 254: 97-102 [PMID: 21494121 DOI: 10.1097/ SLA.0b013e3182196e1f]
2. Lim YK, Law WL, Liu R, Poon JT, Fan JF, Lo OS. Impact of neoadjuvant treatment on total mesorectal excision for ultralow rectal cancers. World J Surg Oncol 2010; 8: 23 [PMID; 20346160 DOI: 10.1186/1477-7819-8-23]
3. Topova L, Hellmich G, Puffer E, Schubert C, Christen N, Boldt T, Wiedemann B, Witzigmann H, Stelzner S. Prognostic value of tumor response to neoadjuvant therapy in rectal carcinoma. Dis Colon Rectum 2011; 54: 401-411 [PMID; 21383559 DOI: 10.1007/DCR.0b013e3182070efb]
4. Roh MS, Colangelo LH, O'Connell MJ, Yothers G, Deutsch M, Allegra CJ, Kahlenberg MS, Baez-Diaz L, Ursiny CS, Petrelli NJ, Wolmark N. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009; 27: 5124-5130 [PMID: 19770376 DOI: 10.1200/jco.2009.22.0467]
5. Kusters M, Holman FA, Martijn H, Nieuwenhuijzen GA, Creemers GJ, Daniels-Gooszen AW, van den Berg HA, van den Brule AJ, van de Velde CJ, Rutten HJ. Patterns of local recurrence in locally advanced rectal cancer after intraoperative radiotherapy containing multimodality treatment. Radiother Oncol 2009; 92: 221-225 [PMID: 19339070 DOI: 10.1016/j.radonc.2009.03.002]
6. Coco C, Valentini V, Manno A, Mattana C, Verbo A, Cellini N, Gambacorta MA, Covino M, Mantini G, Miccichè F, Pedretti G, Petito L, Rizzo G, Cosimelli M, Impiombato FA, Picciocchi A. Long-term results after neoadjuvant radiochemotherapy for locally advanced resectable extraperitoneal rectal cancer. Dis Colon Rectum 2006; 49: 311-318 [PMID; 16456636 DOI: 10.1007/s10350-005-0291-6]
7. Fucini C, Pucciani F, Elbetti C, Gattai R, Russo A. Preoperative radiochemotherapy in t3 operable low rectal cancers: a gold standard? World J Surg 2010; 34: 1609-1614 [PMID; 20213202 DOI: 10.1007/s00268-010-0513-5]
8. Law WL, Chu KW. Local recurrence following total mesorectal excision with double-stapling anastomosis for rectal cancers: analysis of risk factors. World J Surg 2002; 26: 1272-1276 [PMID: 12205546 DOI: 10.1007/s00268-002-6560-9]
9. Habr-Gama A, Perez RO, Proscurshim I, Campos FG, Nadalin W, Kiss D, Gama-Rodrigues J. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg 2006; 10: 1319-1328; discussion 1319-1328; [PMID: 17175450 DOI: 10.1016/j.gassur.2006.09.005]
10. Dresen RC, Peters EE, Rutten HJ, Nieuwenhuijzen GA, Demeyere TB, van den Brule AJ, Kessels AG, Beets-Tan RG, van Krieken JH, Nagtegaal ID. Local recurrence in rectal cancer can be predicted by histopathological factors. Eur J Surg Oncol 2009; 35: 1071-1077 [PMID: 19364631 DOI: 10.1016/ j.ejso.2009.03.007]
11. Maas M, Nelemans PJ, Valentini V, Das P, Rödel C, Kuo LJ, Calvo FA, García-Aguilar J, Glynne-Jones R, Haustermans K, Mohiuddin M, Pucciarelli S, Small W, Suárez J, Theodoropoulos G, Biondo S, Beets-Tan RG, Beets GL. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol 2010; 11: 835-844 [PMID; 20692872 DOI: 10.1016/s1470-2045(10)70172-8]
12. Kusters M, Marijnen CA, van de Velde CJ, Rutten HJ, Lahaye MJ, Kim JH, Beets-Tan RG, Beets GL. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol 2010; 36: 470-476 [PMID: 20096534 DOI: 10.1016/j.ejso.2009.11.011]
13. Ahmad NR, Nagle D. Long-term results of preoperative radiation therapy alone for stage T3 and T4 rectal cancer. Br J Surg 1997; 84: 1445-1448 [PMID: 9361610]
14. Chmielarz A, Kryj M, Wloch J, Półtorak S, Sacher A, Lasek-Kryj M. Prognostic factors for the time of occurrence and dynamics of distant metastases and local recurrences after radical treatment in patients with rectal cancer. Med Sci Monit 2001; 7: 1263-1269 [PMID: 11687740]
15. Francois Y, Nemoz CJ, Baulieux J, Vignal J, Grandjean JP, Partensky C, Souquet JC, Adeleine P, Gerard JP. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 1999; 17: 2396 [PMID: 10561302]
16. Tulchinsky H, Shmueli E, Figer A, Klausner JM, Rabau M. An interval > 7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and diseasefree survival in patients with locally advanced rectal cancer. Ann Surg Oncol 2008; 15: 2661-2667 [PMID: 18389322 DOI: 10.1245/s10434-008-9892-3]
17. Nijkamp J, Kusters M, Beets-Tan RG, Martijn H, Beets GL, van de Velde CJ, Marijnen CA. Three-dimensional analysis of recurrence patterns in rectal cancer: the cranial border in hypofractionated preoperative radiotherapy can be lowered. Int J Radiat Oncol Biol Phys 2011; 80: 103-110 [PMID: 20646849 DOI: 10.1016/j.ijrobp.2010.01.046]
18. Yu TK, Bhosale PR, Crane CH, Iyer RB, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Das P. Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 2008; 71: 1175-1180 [PMID: 18207667 DOI: 10.1016/ j.ijrobp.2007.11.018]
19. den Dulk M, Collette L, van de Velde CJ, Marijnen CA, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bosset JF. Quality of surgery in T3-4 rectal cancer: involvement of circumferential resection margin not influenced by preoperative treatment. Results from EORTC trial 22921. Eur J Cancer 2007; 43: 1821-1828 [PMID: 17627809 DOI: 10.1016/ j.ejca.2007.05.025]
20. Syk E, Torkzad MR, Blomqvist L, Nilsson PJ, Glimelius B. Local recurrence in rectal cancer: anatomic localization and effect on radiation target. Int J Radiat Oncol Biol Phys 2008; 72: 658-664 [PMID: 18495376 DOI: 10.1016/j.ijrobp.2008.01.063]
21. Kusters M, Wallner C, Lange MM, DeRuiter MC, van de Velde CJ, Moriya Y, Rutten HJ. Origin of presacral local recurrence after rectal cancer treatment. Br J Surg 2010; 97: 1582-1587 [PMID: 20641063 DOI: 10.1002/bjs.7180]
22. Wang C, Zhou ZG, Yu YY, Li Y, Lei WZ, Cheng Z, Chen ZX. Patterns of lateral pelvic lymph node metastases and micrometastases for patients with lower rectal cancer. Eur J Surg Oncol 2007; 33: 463-467 [PMID: 17081722 DOI: 10.1016/ j.ejso.2006.09.015]
23. Homma Y, Hamano T, Otsuki Y, Shimizu S, Kobayashi H, Kobayashi Y. Severe tumor budding is a risk factor for lateral lymph node metastasis in early rectal cancers. J Surg Oncol 2010; 102: 230-234 [PMID: 20740580 DOI: 10.1002/jso.21606]
24. Syk E, Lenander C, Nilsson PJ, Rubio CA, Glimelius B. Tumour budding correlates with local recurrence of rectal cancer. Colorectal Dis 2011; 13: 255-262 [PMID: 19912282 DOI: 10.1111/j.1463-1318.2009.02119.x]
25. Glimelius B, Oliveira J. Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009; 20 Suppl 4: 54-56 [PMID: 19454463 DOI: 10.1093/ annonc/mdp128]
26. Merkel S, Mansmann U, Hohenberger W, Hermanek P. Time to locoregional recurrence after curative resection of rectal carcinoma is prolonged after neoadjuvant treatment: a systematic review and meta-analysis. Colorectal Dis 2011; 13: 123-131 [PMID: 19895596 DOI: 10.1111/j.1463-1318.2009.02110.x]
27. Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, Quirke P, Couture J, de Metz C, Myint AS, Bessell E, Griffiths G, Thompson LC, Parmar M. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009; 373: 811-820 [PMID: 19269519 DOI: 10.1016/ s0140-6736(09)60484-0]
28. Prall F. Tumour budding in colorectal carcinoma. Histopathology 2007; 50: 151-162 [PMID: 17204028 DOI: 10.1111/ j.1365-2559.2006.02551.x]
29. Sy J, Fung CL, Dent OF, Chapuis PH, Bokey L, Chan C. Tumor budding and survival after potentially curative resection of node-positive colon cancer. Dis Colon Rectum 2010; 53: 301-307 [PMID: 20173477 DOI: 10.1007/ DCR.0b013e3181c3ed05]
30. Kanazawa H, Mitomi H, Nishiyama Y, Kishimoto I, Fukui N, Nakamura T, Watanabe M. Tumour budding at invasive margins and outcome in colorectal cancer. Colorectal Dis 2008; 10: 41-47 [PMID: 18078460 DOI: 10.1111/ j.1463-1318.2007.01240.x]
31. Gavioli M, Luppi G, Losi L, Bertolini F, Santantonio M, Falchi AM, D'Amico R, Conte PF, Natalini G. Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer. Dis Colon Rectum 2005; 48: 1851-1857 [PMID: 16132481 DOI: 10.1007/s10350-005-0133-6]
32. Chmielik E, Bujko K, Nasierowska-Guttmejer A, Nowacki MP, Kepka L, Sopylo R, Wojnar A, Majewski P, Sygut J, Karmolinski A, Huzarski T, Wandzel P. Distal intramural spread of rectal cancer after preoperative radiotherapy: the results of a multicenter randomized clinical study. Int J Radiat Oncol Biol Phys 2006; 65: 182-188 [PMID: 16530338 DOI: 10.1016/j.ijrobp.2005.11.039]
33. Kuvshinoff B, Maghfoor I, Miedema B, Bryer M, Westgate S, Wilkes J, Ota D. Distal margin requirements after preoperative chemoradiotherapy for distal rectal carcinomas: are & lt; or = 1 cm distal margins sufficient? Ann Surg Oncol 2001; 8: 163-169 [PMID: 11258782]
34. Moore HG, Riedel E, Minsky BD, Saltz L, Paty P, Wong D, Cohen AM, Guillem JG. Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol 2003; 10: 80-85 [PMID: 12513965]
35. Nash GM, Weiss A, Dasgupta R, Gonen M, Guillem JG, Wong WD. Close distal margin and rectal cancer recurrence after sphincter-preserving rectal resection. Dis Colon Rectum 2010; 53: 1365-1373 [PMID: 20847617 DOI: 10.1007/ DCR.0b013e3181f052d4]
36. Guillem JG, Chessin DB, Shia J, Suriawinata A, Riedel E, Moore HG, Minsky BD, Wong WD. A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation. Ann Surg 2007; 245: 88-93 [PMID: 17197970 DOI: 10.1097/01.sla.0000232540.82364.43]
37. Mezhir JJ, Smith KD, Fichera A, Hart J, Posner MC, Hurst RD. Presence of distal intramural spread after preoperative combined-modality therapy for adenocarcinoma of the rectum: what is now the appropriate distal resection margin? Surgery 2005; 138: 658-663; discussion 663-664 [PMID; 16269294 DOI: 10.1016/j.surg.2005.06.048]
38. Prabhudesai A, Arif S, Finlayson CJ, Kumar D. Impact of microscopic extranodal tumor deposits on the outcome of patients with rectal cancer. Dis Colon Rectum 2003; 46: 1531-1537 [PMID: 14605575 DOI: 10.1097/01.dcr.0000093639.11640.51]
39. Ratto C, Ricci R, Valentini V, Castri F, Parello A, Gambacorta MA, Cellini N, Vecchio FM, Doglietto GB. Neoplastic mesorectal microfoci (MMF) following neoadjuvant chemoradiotherapy: clinical and prognostic implications. Ann Surg Oncol 2007; 14: 853-861 [PMID: 17103068 DOI: 10.1245/ s10434-006-9163-0]
40. Ratto C, Ricci R, Rossi C, Morelli U, Vecchio FM, Doglietto GB. Mesorectal microfoci adversely affect the prognosis of patients with rectal cancer. Dis Colon Rectum 2002; 45: 733-42; discussion 742-3 [PMID: 12072622]
41. Umlaufová D, Skapa P, Hoch J, Prausová J. [Incidence and prognostic significance of mesorectal extranodal tumor deposits in patients with rectal carcinoma following neoadjuvant therapy]. Rozhl Chir 2009; 88: 326-329 [PMID: 19642326]
42. Zmora O, Dasilva GM, Gurland B, Pfeffer R, Koller M, Nogueras JJ, Wexner SD. Does rectal wall tumor eradication with preoperative chemoradiation permit a change in the operative strategy? Dis Colon Rectum 2004; 47: 1607-1612 [PMID: 15540288]
43. Read TE, Andujar JE, Caushaj PF, Johnston DR, Dietz DW, Myerson RJ, Fleshman JW, Birnbaum EH, Mutch MG, Kodner IJ. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status. Dis Colon Rectum 2004; 47: 825-831 [PMID: 15108025 DOI: 10.1007/ s10350-004-0535-x]
44. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Kepka L, Winkler-Spytkowska B, Suwiński R, Oledzki J, Stryczyńska G, Wieczorek A, Serkies K, Rogowska D, Tokar P. Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: results of a randomised trial: implication for subsequent local excision. Radiother Oncol 2005; 76: 234-240 [PMID: 16273666]
45. Pucciarelli S, Capirci C, Emanuele U, Toppan P, Friso ML, Pennelli GM, Crepaldi G, Pasetto L, Nitti D, Lise M. Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer. Ann Surg Oncol 2005; 12: 111-116 [PMID; 15827790 DOI: 10.1245/aso.2005.03.044]
46. Tulchinsky H, Rabau M, Shacham-Shemueli E, Goldman G, Geva R, Inbar M, Klausner JM, Figer A. Can rectal cancers with pathologic T0 after neoadjuvant chemoradiation (ypT0) be treated by transanal excision alone? Ann Surg Oncol 2006; 13: 347-352 [PMID: 16450221 DOI: 10.1245/ASO.2006.03.029]
47. Habr-Gama A, Perez RO, Proscurshim I, Rawet V, Pereira DD, Sousa AH, Kiss D, Cecconello I. Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean? Dis Colon Rectum 2008; 51: 277-283 [PMID; 18183463 DOI: 10.1007/s10350-007-9148-5]
48. Stipa F, Zernecke A, Moore HG, Minsky BD, Wong WD, Weiser M, Paty PB, Shia J, Guillem JG. Residual mesorectal lymph node involvement following neoadjuvant combinedmodality therapy: rationale for radical resection? Ann Surg Oncol 2004; 11: 187-191 [PMID: 14761922]
49. Kundel Y, Brenner R, Purim O, Peled N, Idelevich E, Fenig E, Sulkes A, Brenner B. Is local excision after complete pathological response to neoadjuvant chemoradiation for rectal cancer an acceptable treatment option? Dis Colon Rectum 2010; 53: 1624-1631 [PMID: 21178856 DOI: 10.1007/ DCR.0b013e3181f5b64d]
50. Kim DW, Kim DY, Kim TH, Jung KH, Chang HJ, Sohn DK, Lim SB, Choi HS, Jeong SY, Park JG. Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer? Cancer 2006; 106: 1694-1700 [PMID: 16532432 DOI: 10.1002/cncr.21794]
51. Lindebjerg J, Spindler KL, Ploen J, Jakobsen A. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy. Colorectal Dis 2009; 11: 264-269 [PMID: 18573119 DOI: 10.1111/j.1463-1318.2008.01599.x]
52. Coco C, Manno A, Mattana C, Verbo A, Rizzo G, Valentini V, Gambacorta MA, Vecchio FM, D'Ugo D. The role of local excision in rectal cancer after complete response to neoadjuvant treatment. Surg Oncol 2007; 16 Suppl 1: S101-S104 [PMID: 18023178 DOI: 10.1016/j.suronc.2007.10.008]
53. Bonnen M, Crane C, Vauthey JN, Skibber J, Delclos ME, Rodriguez-Bigas M, Hoff PM, Lin E, Eng C, Wong A, Janjan NA, Feig BW. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiat Oncol Biol Phys 2004; 60: 1098-1105 [PMID: 15519780 DOI: 10.1016/j.ijrobp.2004.04.062]
54. Hershman MJ, Myint AS, Makin CA. Multi-modality approach in curative local treatment of early rectal carcinomas. Colorectal Dis 2003; 5: 445-450 [PMID: 12925078]
55. Lezoche E, Guerrieri M, Paganini AM, Baldarelli M, De Sanctis A, Lezoche G. Long-term results in patients with T2-3 N0 distal rectal cancer undergoing radiotherapy before transanal endoscopic microsurgery. Br J Surg 2005; 92: 1546-1552 [PMID: 16252312 DOI: 10.1002/bjs.5178]
56. Schell SR, Zlotecki RA, Mendenhall WM, Marsh RW, Vauthey JN, Copeland EM. Transanal excision of locally advanced rectal cancers downstaged using neoadjuvant chemoradiotherapy. J Am Coll Surg 2002; 194: 584-590; discussion 590-591 [PMID: 12025835]
57. Stipa F, Chessin DB, Shia J, Paty PB, Weiser M, Temple LK, Minsky BD, Wong WD, Guillem JG. A pathologic complete response of rectal cancer to preoperative combinedmodality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography. Ann Surg Oncol 2006; 13: 1047-1053 [PMID: 16865595 DOI: 10.1245/ aso.2006.03.053]
58. Ruo L, Guillem JG, Minsky BD, Quan SH, Paty PB, Cohen AM. Preoperative radiation with or without chemotherapy and full-thickness transanal excision for selected T2 and T3 distal rectal cancers. Int J Colorectal Dis 2002; 17: 54-58 [PMID: 12018456]
59. Kim CJ, Yeatman TJ, Coppola D, Trotti A, Williams B, Barthel JS, Dinwoodie W, Karl RC, Marcet J. Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg 2001; 234: 352-358; discussion 352-358 [PMID: 11524588]
60. Borschitz T, Wachtlin D, Möhler M, Schmidberger H, Junginger T. Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol 2008; 15: 712-720 [PMID; 18163173 DOI: 10.1245/s10434-007-9732-x]
61. Nair RM, Siegel EM, Chen DT, Fulp WJ, Yeatman TJ, Malafa MP, Marcet J, Shibata D. Long-term results of transanal excision after neoadjuvant chemoradiation for T2 and T3 adenocarcinomas of the rectum. J Gastrointest Surg 2008; 12: 1797-1805; discussion 1805-1806 [PMID: 18709419 DOI: 10.1007/s11605-008-0647-z]
62. Callender GG, Das P, Rodriguez-Bigas MA, Skibber JM, Crane CH, Krishnan S, Delclos ME, Feig BW. Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer. Ann Surg Oncol 2010; 17: 441-447 [PMID; 19847569 DOI: 10.1245/s10434-009-0735-7]
63. Park C, Lee W, Han S, Yun S, Chun HK. Transanal local excision for preoperative concurrent chemoradiation therapy for distal rectal cancer in selected patients. Surg Today 2007; 37: 1068-1072 [PMID: 18030568 DOI: 10.1007/s00595-007-3547-z]
64. Yeo SG, Kim DY, Kim TH, Chang HJ, Oh JH, Park W, Choi DH, Nam H, Kim JS, Cho MJ, Kim JH, Park JH, Kang MK, Koom WS, Kim JS, Nam TK, Chie EK, Kim JS, Lee KJ. Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01). Ann Surg 2010; 252: 998-1004 [PMID: 21107110 DOI: 10.1097/ SLA.0b013e3181f3f1b1]
65. Perez RO, Habr-Gama A, Proscurshim I, Campos FG, Kiss D, Gama-Rodrigues J, Cecconello I. Local excision for ypT2 rectal cancer--much ado about something. J Gastrointest Surg 2007; 11: 1431-1438; discussion 1431-1438 [PMID: 17805938 DOI: 10.1007/s11605-007-0271-3]
66. Perez RO, Habr-Gama A, Nishida Arazawa ST, Rawet V, Coelho Siqueira SA, Kiss DR, Gama-Rodrigues JJ. Lymph node micrometastasis in stage II distal rectal cancer following neoadjuvant chemoradiation therapy. Int J Colorectal Dis 2005; 20: 434-439 [PMID: 15759124 DOI: 10.1007/ s00384-004-0712-3]
67. Koda K, Saito N, Oda K, Takiguchi N, Sarashina H, Miyazaki M. Evaluation of lateral lymph node dissection with preoperative chemo-radiotherapy for the treatment of advanced middle to lower rectal cancers. Int J Colorectal Dis 2004; 19: 188-194 [PMID: 14634773 DOI: 10.1007/s00384-003-0548-2]
68. Ueno M, Oya M, Azekura K, Yamaguchi T, Muto T. Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br J Surg 2005; 92: 756-763 [PMID: 15838895 DOI: 10.1002/bjs.4975]
69. Moriya Y, Sugihara K, Akasu T, Fujita S. Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. World J Surg 1997; 21: 728-732 [PMID: 9276704]
70. Hiotis SP, Weber SM, Cohen AM, Minsky BD, Paty PB, Guillem JG, Wagman R, Saltz LB, Wong WD. Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg 2002; 194: 131-135; discussion 131-135 [PMID: 11848629]
71. Hughes R, Glynne-Jones R, Grainger J, Richman P, Makris A, Harrison M, Ashford R, Harrison RA, Livingstone JI, McDonald PJ, Meyrick Thomas J, Mitchell IC, Northover JM, Phillips R, Wallace M, Windsor A, Novell JR. Can pathological complete response in the primary tumour following preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision? Int J Colorectal Dis 2006; 21: 11-17 [PMID: 15864605 DOI: 10.1007/s00384-005-0749-y]
72. Kim TH, Jeong SY, Choi DH, Kim DY, Jung KH, Moon SH, Chang HJ, Lim SB, Choi HS, Park JG. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 2008; 15: 729-737 [PMID; 18057989 DOI: 10.1245/s10434-007-9696-x]
73. Kusters M, van de Velde CJ, Beets-Tan RG, Akasu T, Fujita S, Yamamoto S, Moriya Y. Patterns of local recurrence in rectal cancer: a single-center experience. Ann Surg Oncol 2009; 16: 289-296 [PMID: 19015921 DOI: 10.1245/s10434-008-0223-5]
74. Georgiou P, Tan E, Gouvas N, Antoniou A, Brown G, Nicholls RJ, Tekkis P. Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol 2009; 10: 1053-1062 [PMID: 19767239 DOI: 10.1016/ s1470-2045(09)70224-4]
75. Sugihara K, Kobayashi H, Kato T, Mori T, Mochizuki H, Kameoka S, Shirouzu K, Muto T. Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 2006; 49: 1663-1672 [PMID: 17041749 DOI: 10.1007/s10350-006-0714-z]
76. Farnault B, Moureau-Zabotto L, de Chaisemartin C, Esterni B, Lelong B, Viret F, Giovannini M, Monges G, Delpero JR, Bories E, Turrini O, Viens P, Resbeut M. [Predictive factors of tumour response after neoadjuvant chemoradiation for locally advanced rectal cancer and correlation of these factors with survival]. Cancer Radiother 2011; 15: 279-286 [PMID; 21515083 DOI: 10.1016/j.canrad.2011.01.005]
77. Luna-Pérez P, Rodríguez-Ramírez S, Hernández-Pacheco F, Gutiérrez De La Barrera M, Fernández R, Labastida S. Anal sphincter preservation in locally advanced low rectal adenocarcinoma after preoperative chemoradiation therapy and coloanal anastomosis. J Surg Oncol 2003; 82: 3-9 [PMID; 12501163 DOI: 10.1002/jso.10185]
78. Janjan NA, Khoo VS, Abbruzzese J, Pazdur R, Dubrow R, Cleary KR, Allen PK, Lynch PM, Glober G, Wolff R, Rich TA, Skibber J. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 1999; 44: 1027-1038 [PMID: 10421535]
79. Medich D, McGinty J, Parda D, Karlovits S, Davis C, Caushaj P, Lembersky B. Preoperative chemoradiotherapy and radical surgery for locally advanced distal rectal adenocarcinoma: pathologic findings and clinical implications. Dis Colon Rectum 2001; 44: 1123-1128 [PMID: 11535851]
80. Habr-Gama A, Perez RO, Nadalin W, Nahas SC, Ribeiro U, Silva E Sousa AH, Campos FG, Kiss DR, Gama-Rodrigues J. Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival. J Gastrointest Surg 2005; 9: 90-99; discussion 99-101 [PMID; 15623449 DOI: 10.1016/j.gassur.2004.10.010]
81. Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, Roussel A, Jacob JH, Segol P, Samama G. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994; 73: 2680-2686 [PMID: 8194005]
82. Kim NK, Baik SH, Seong JS, Kim H, Roh JK, Lee KY, Sohn SK, Cho CH. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival. Ann Surg 2006; 244: 1024-1030 [PMID; 17122629 DOI: 10.1097/01.sla.0000225360.99257.73]
83. Kuo LJ, Liu MC, Jian JJ, Horng CF, Cheng TI, Chen CM, Fang WT, Chung YL. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Ann Surg Oncol 2007; 14: 2766-2772 [PMID: 17551794 DOI: 10.1245/s10434-007-9471-z]
84. Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2005; 61: 665-677 [PMID: 15708244 DOI: 10.1016/j.ijrobp.2004.06.206]
85. Vecchio FM, Valentini V, Minsky BD, Padula GD, Venkatraman ES, Balducci M, Miccichè F, Ricci R, Morganti AG, Gambacorta MA, Maurizi F, Coco C. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 2005; 62: 752-760 [PMID: 15936556 DOI: 10.1016/ j.ijrobp.2004.11.017]
86. García-Aguilar J, Hernandez de Anda E, Sirivongs P, Lee SH, Madoff RD, Rothenberger DA. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 2003; 46: 298-304 [PMID: 12626903 DOI: 10.1097/01. dcr.0000054637.75996.df]
87. Wheeler JM, Dodds E, Warren BF, Cunningham C, George BD, Jones AC, Mortensen NJ. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade. Dis Colon Rectum 2004; 47: 2025-2031 [PMID: 15657650 DOI: 10.1007/s10350-004-0713-x]
88. Theodoropoulos G, Wise WE, Padmanabhan A, Kerner BA, Taylor CW, Aguilar PS, Khanduja KS. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 2002; 45: 895-903 [PMID: 12130878]
89. Nyasavajjala SM, Shaw AG, Khan AQ, Brown SR, Lund JN. Neoadjuvant chemo-radiotherapy and rectal cancer: can the UK watch and wait with Brazil? Colorectal Dis 2010; 12: 33-36 [PMID: 19832875 DOI: 10.1111/j.1463-1318.2009.02054.x]
90. Nakagawa WT, Rossi BM, de O'Ferreira F, Ferrigno R, David Filho WJ, Nishimoto IN, Vieira RA, Lopes A. Chemoradiation instead of surgery to treat mid and low rectal tumors: is it safe? Ann Surg Oncol 2002; 9: 568-573 [PMID: 12095973]
91. Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro U, Silva e Sousa AH, Campos FG, Kiss DR, Gama-Rodrigues J. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 2004; 240: 711-717; discussion 711-717 [PMID: 15383798]
92. van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, Rutten HJ, Påhlman L, Glimelius B, van de Velde CJ. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011; 12: 575-582 [PMID: 21596621 DOI: 10.1016/s1470-2045(11)70097-3]
93. den Dulk M, Putter H, Collette L, Marijnen CA, Folkesson J, Bosset JF, Rödel C, Bujko K, Påhlman L, van de Velde CJ. The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer. Eur J Cancer 2009; 45: 1175-1183 [PMID; 19128956 DOI: 10.1016/j.ejca.2008.11.039]
94. den Dulk M, Marijnen CA, Putter H, Rutten HJ, Beets GL, Wiggers T, Nagtegaal ID, van de Velde CJ. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. Ann Surg 2007; 246: 83-90 [PMID: 17592295 DOI: 10.1097/01.sla.0000259432.29056.9d]
95. Bülow S, Christensen IJ, Iversen LH, Harling H. Intra-operative perforation is an important predictor of local recurrence and impaired survival after abdominoperineal resection for rectal cancer. Colorectal Dis 2011; 13: 1256-1264 [PMID; 20958912 DOI: 10.1111/j.1463-1318.2010.02459.x]
96. Jörgren F, Johansson R, Damber L, Lindmark G. Anastomotic leakage after surgery for rectal cancer: a risk factor for local recurrence, distant metastasis and reduced cancerspecific survival? Colorectal Dis 2011; 13: 272-283 [PMID; 19912285 DOI: 10.1111/j.1463-1318.2009.02136.x]
97. Harris LJ, Phillips BR, Maxwell PJ, Isenberg GA, Goldstein SD. Outcomes of low anterior resection anastomotic leak after preoperative chemoradiation therapy for rectal cancer. Am Surg 2010; 76: 747-751 [PMID: 20698384]
98. Hurst PA, Prout WG, Kelly JM, Bannister JJ, Walker RT. Local recurrence after low anterior resection using the staple gun. Br J Surg 1982; 69: 275-276 [PMID: 7074339]
99. Anderberg B, Enblad P, Sjödahl R, Wetterfors J. Recurrent rectal carcinoma after anterior resection and rectal stapling. Br J Surg 1984; 71: 98-100 [PMID: 6692125]
100. Kodeda K, Holmberg E, Jörgren F, Nordgren S, Lindmark G. Rectal washout and local recurrence of cancer after anterior resection. Br J Surg 2010; 97: 1589-1597 [PMID: 20672364 DOI: 10.1002/bjs.7182]
101. Maeda K, Maruta M, Hanai T, Sato H, Horibe Y. Irrigation volume determines the efficacy of "rectal washout". Dis Colon Rectum 2004; 47: 1706-1710 [PMID: 15540303]